Skip main navigation

End of Week 2

A summary of what has been discussed in week two and what learners have learnt.
End written in chalk on the pavement
© BSAC

Well done on reaching the end of Week 2! We hope you enjoyed it. You should now have gained an understanding of:

  • How vaccine safety is assessed and monitored

  • Specific safety concerns related to vaccine associated disease enhancement

  • The difference between vaccine efficacy and effectiveness and how these are measured

  • Why efficacy assessment of COVID-19 vaccines in Phase III studies is difficult

  • How COVID-19 controlled human infection model studies could accelerate vaccine development and concerns regarding their use

Next week, we will look at some case studies where vaccines have been used to control infectious disease outbreaks. We will also learn about the different candidates for a COVID-19 vaccine.

See you in week 3!

© BSAC
This article is from the free online

Vaccine Development: Finding a Vaccine for COVID-19 and Future Pandemics

Created by
FutureLearn - Learning For Life

Our purpose is to transform access to education.

We offer a diverse selection of courses from leading universities and cultural institutions from around the world. These are delivered one step at a time, and are accessible on mobile, tablet and desktop, so you can fit learning around your life.

We believe learning should be an enjoyable, social experience, so our courses offer the opportunity to discuss what you’re learning with others as you go, helping you make fresh discoveries and form new ideas.
You can unlock new opportunities with unlimited access to hundreds of online short courses for a year by subscribing to our Unlimited package. Build your knowledge with top universities and organisations.

Learn more about how FutureLearn is transforming access to education